ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
These initiatives aim to improve access to healthcare for rare disease patients
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
Rocuronium Bromide Injection is a neuromuscular blocking agent
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO
Subscribe To Our Newsletter & Stay Updated
